Large-scale evidence to quantify and address gender-based variation in cardiovascular disease
- Years funded:
- 2018 - 2019
Cardiovascular disease (CVD) remains the single biggest killer and the second greatest source of disability in women in Australia.
CVD has long been considered a disease primarily affecting men and current attempts to improve outcomes are hampered by the lack of quantitative, in-depth and integrated evidence regarding gender-based variation across the “CVD journey”, from risk factors to the outcomes of people living with CVD.
To address this, an experienced multidisciplinary team will draw on seven data sources, including nationally representative surveys, large-scale linked data and detailed clinical datasets.
It will quantify outcomes in, and ascertain relative and absolute differences between, women and men, including for: (i) CVD risk factors and prevention of future heart attacks and strokes; (ii) CVD hospital admissions and deaths from different types of CVD, including heart attacks, strokes, heart failure and peripheral vascular disease; (iii) the receipt of CVD procedures in hospital following an acute CVD event including secondary preventative measures; (iv) physical disability, psychological distress and quality of life after a CVD event.
Preliminary data demonstrates feasibility and stark disparities in care and outcomes.
When the project is complete, Australia will have integrated data on gender disparity for multiple CVD types across the CVD journey, supporting targeted intervention to improve prevention, care and outcomes for CVD in women.
Professor Emily Banks
|Institute:||The Sax Institute|